News

According to the company, these actions are being taken to manage capital resources while Panacos pursues strategic alternatives, including the financing, partnering or sale of the company or

Crofelemer is Napo’s novel anti-secretory, gastrointestinal agent currently in a final Phase III trial for the treatment of chronic diarrhea in people living with HIV/AIDS (the ADVENT program)

KAI’s double-blind, randomized, placebo- and active-comparator-controlled, single-dose study will evaluate the efficacy of KAI-1678 administered by subcutaneous infusion for the treatment of postoperative pain. The primary endpoint of

The content and schedule for submitting the modules, which represent major sections of the entire premarket approval (PMA) application, were agreed to in advance by Guided Therapeutics (GT)

The vote was 16 against, one in favor and one abstention. The committee also discussed concerns that it would like addressed to support approval of the product for

The preclinical study compared Crucell’s monoclonal antibody (mAb) CR6261 with the anti-influenza drug oseltamivir in terms of their value for flu prevention and treatment. The flu strains tested

Early analysis of the Phase II multiple myeloma (MM) study, in which half of the 60 patients with relapsed MM received combined low-dose dexamethasone with pomalidomide, showed that

In the approval, the FDA required that Lusedra be used only by persons trained in the administration of general anesthesia and that all patients should be continuously monitored

As a result of this ruling, the patent protection for this product is maintained in the US until November 2011. Sanofi-Aventis and Bristol-Myers Squibb are seeking damages from